This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit US
November 5 - 7, 2024
The Royal Sonesta Minneapolis DowntownMinneapolis, Minnesota

Frances Hsia, MS, MPH, DABT
Toxicologist Fellow at Boston Scientific


Frances is a board-certified toxicologist with over 25 years of experience in conducting biological evaluation of medical devices and toxicological risk assessment. She earned a MPH in toxicology from the University of Minnesota, a MS in molecular biology from Simon Fraser University and a BS in biochemistry from Australian National University. In her careers at Boston Scientific and earlier at 3M, Frances has provided global toxicology support for many different types of products including cardiovascular implant and combination devices, dental devices, health care, industrial and consumer products. She serves as a primary voting member on ISO/TC194 WG01, WG09 and WG11. She is a US delegate on WG11.

Agenda Sessions

  • Industry Perspective: Adhering to ISO 10993-17